NewslettersCancer Stem Cell NewsPancreatic Cell NewsMiR-199 Reverses the Resistance to Gemcitabine in Pancreatic Cancer by Suppressing Stemness through Regulating the Epithelial–Mesenchymal TransitionBy Justin.choi - December 8, 20210163Researchers investigate the function of miR-199 on gemcitabine-resistance in pancreatic cancer, as well as the underlying mechanism.[ACS Omega] 6445212 AAAAAAAA items 1 apa 0 default asc 1 169841 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/Full ArticleGraphical Abstract